In large enterprises, QC labs need to test and document the results for tens of thousands of samples per year. When deviations are identified and investigations follow, these efforts increase substantially.
Read this solution brief to learn how TetraScience can reduce the efforts of biopharmaceutical companies in QC data transfer, validation and compliance, report creation, control charts and trending, and deviations and investigations. TetraScience’s data-centric, science-driven approach can help achieve digital QC, accelerating time-to-clinic and time-to-patient, reducing batch inventory, improving revenue realization, and fulfilling patient needs earlier.
